Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

BACKGROUND: There is strong evidence of under-reporting of harms in manuscripts on randomized controlled trials (RCTs) compared with the volume of raw data retrieved from these trials. Many guidelines have been developed to tackle this, but they have failed to address some important issues that woul...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drugs Aging
Prif Awduron: Honvo, Germain, Bannuru, Raveendhara R., Bruyère, Olivier, Rannou, Francois, Herrero-Beaumont, Gabriel, Uebelhart, Daniel, Cooper, Cyrus, Arden, Nigel, Conaghan, Philip G., Reginster, Jean-Yves, Thomas, Thierry, McAlindon, Tim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer International Publishing 2019
Pynciau:
Leading Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509216/
https://ncbi.nlm.nih.gov/pubmed/31073927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-019-00667-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg